Flotek Industries, Inc. — FY 2014 Form 10-K
Reporting period: Fiscal year ended December 31, 2014. This is an annual filing; fourth-quarter figures are also summarized below. Flotek supplies energy chemicals, drilling and production technologies, and citrus-based consumer and industrial chemicals.
Financial performance
| Metric | FY 2014 | FY 2013 | Change |
|---|---|---|---|
| Revenue | $449.2 million | $371.1 million | Up 21.0% |
| Gross margin | $183.0 million; 40.7% | $147.5 million; 39.8% | Margin up 0.9 percentage points |
| Operating income | $80.9 million; 18.0% | $58.7 million; 15.8% | Up 37.7% |
| Net income | $53.6 million | $36.2 million | Up 48.2% |
| Diluted EPS | $0.97 | $0.67 | Up $0.30 |
| Operating cash flow | $48.8 million | $39.5 million | Up $9.3 million |
Fourth-quarter 2014 revenue was $124.5 million versus $100.8 million in Q4 2013; net income was $16.3 million versus $11.0 million, and diluted EPS was $0.29 versus $0.20.
Growth was led by Energy Chemical Technologies: revenue rose 33.8% to $268.8 million, with segment operating income of $84.8 million. Drilling Technologies revenue was nearly flat at $113.3 million, while gross margin improved to 40.3%. Consumer and Industrial Chemical Technologies generated $51.1 million revenue, reflecting a full-year contribution from Florida Chemical, acquired in May 2013. Production Technologies revenue increased 8.1% to $16.0 million.
Liquidity, debt and capital
- Cash and cash equivalents were $1.3 million at year-end, down from $2.7 million.
- Total borrowings were $44.0 million: $8.5 million drawn on a $75 million revolving facility and $35.5 million under the term loan. Available revolver capacity was $57.8 million; the company reported compliance with debt covenants.
- Operating cash flow of $48.8 million included a $28.9 million working-capital use, primarily from higher inventory and receivables. Capital expenditures were $19.9 million.
- Stockholders’ equity was $306.0 million and total assets were $423.3 million. The company repurchased $10.4 million of common stock in 2014; $14.6 million remained authorized. It reported no plans to pay cash dividends.
Changes, outlook and risks
- Revenue and operating profit increased year over year; consolidated gross margin improved, supported in part by stronger Drilling Technologies margins and increased Energy Chemical sales. SG&A as a share of revenue declined to 19.4% from 21.1%.
- Florida Chemical contributed a full year of results in 2014. Flotek also acquired EOGA, an enhanced oil recovery firm, and SiteLark, a reservoir engineering and modeling company.
- Management reported that crude oil prices fell sharply in the second half of 2014 and continued lower in early 2015. It expected customer spending cuts and a more challenging market for energy-related products in North America and internationally.
- Management planned approximately $25 million of 2015 capital spending, including about $10 million for a Houston research headquarters and an Oman chemistry facility. It expected operating cash flow and available revolver capacity to support planned investment and debt payments, while retaining flexibility to adjust spending.
- Key exposures include oil and gas price and activity declines, customer concentration and collection risk, competition, citrus crop and input-cost volatility, supplier availability, environmental and hydraulic-fracturing regulation, foreign operations and currency exposure, variable interest rates, and execution/integration risks. Three customers represented 29% of 2014 revenue collectively; one represented 16%.
- Unusual or notable items: a $2.0 million inventory write-down during 2014; no goodwill or other long-lived asset impairment was recorded. The company reported no pending or threatened litigation expected to have a material financial effect. The independent auditor issued unqualified opinions on the financial statements and internal control over financial reporting.
Most important facts for investors to verify
- How quickly 2015 oil-price-related customer spending cuts affect revenue, margins, receivables and inventory.
- Whether the reported 2014 growth in proprietary stimulation chemistry and FracMax-supported sales is sustainable and translates into cash generation.
- Liquidity and debt-service capacity given low year-end cash, variable-rate borrowings, working-capital requirements and planned 2015 capital spending.
- Customer concentration, payment collectability and exposure to major oilfield-service and exploration customers.
- Execution, cost and expected returns for the planned research and Oman facilities, and integration of the 2014 acquisitions.